Search Browse Earnings

AMARIN CORP PLC\UK — SlamSEC

AMARIN CORP PLC\UK

Nasdaq:AMRN

Pharmaceutical Preparations·DUBLIN 2

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$306.9M

-16.9% YoY

FY 2025

Adj. EBITDA

-$67.5M

-22.0% margin

FY 2025

Net Income

-$59.1M

-19.3% margin

FY 2025

EPS (Diluted)

-$0.15

FY 2025

Stock Price

$16.32

+2.3%

2026-03-11

52W Range

$7.08 – $20.90

P/E Ratio

-108.8x

Market Cap

$6.2M

Cash

$121.0M

FY 2025

Total Debt

$46.1M

FY 2019

Net Cash

$74.9M

FY 2019

Enterprise Value

-$68.7M

Debt / EBITDA

1.1x

FY 2025

EV / EBITDA

1.0x

Employees

—